2014
DOI: 10.1073/pnas.1405414111
|View full text |Cite
|
Sign up to set email alerts
|

Two apextrin-like proteins mediate extracellular and intracellular bacterial recognition in amphioxus

Abstract: Animals exploit different germ-line-encoded proteins with various domain structures to detect the signature molecules of pathogenic microbes. These molecules are known as pathogen-associated molecular patterns (PAMPs), and the host proteins that react with PAMPs are called pattern recognition proteins (PRPs). Here, we present a novel type of protein domain structure capable of binding to bacterial peptidoglycan (PGN) and the minimal PGN motif muramyl dipeptide (MDP). This domain is designated as apextrin C-ter… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
32
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(33 citation statements)
references
References 44 publications
1
32
0
Order By: Relevance
“…Using a de novo method, we identified 941 candidate novel domains that are conserved in the two lancelets but absent in vertebrates; the 375 most confident candidates were distributed in 1,884 proteins ( Supplementary Figs 30 and 31 ; Supplementary Note 11 ). We functionally verified one of the candidates, the ApeC domain (deposited in the Pfam database under accession PF16977), as a novel pattern recognition domain for bacterial peptidoglycan 31 . We also used a BLAST-clustering method to directly measure the sequence diversity of all protein domains (vertebrate-specific domains included) in humans, mice, zebrafish, tunicates and lancelets ( Supplementary Note 11 ).…”
Section: Resultsmentioning
confidence: 99%
“…Using a de novo method, we identified 941 candidate novel domains that are conserved in the two lancelets but absent in vertebrates; the 375 most confident candidates were distributed in 1,884 proteins ( Supplementary Figs 30 and 31 ; Supplementary Note 11 ). We functionally verified one of the candidates, the ApeC domain (deposited in the Pfam database under accession PF16977), as a novel pattern recognition domain for bacterial peptidoglycan 31 . We also used a BLAST-clustering method to directly measure the sequence diversity of all protein domains (vertebrate-specific domains included) in humans, mice, zebrafish, tunicates and lancelets ( Supplementary Note 11 ).…”
Section: Resultsmentioning
confidence: 99%
“…The association of ApeC with MACPF, detected in 5 predicted mussel proteins, strongly indicates the combination of pathogen recognition and killing properties in the same protein sequence, as ApeC has been recently functionally linked to pathogen recognition in amphioxus [78] (see Section 3.1.1.8).…”
Section: Evidence Of An Ancient Bivalve Complement-like Systemmentioning
confidence: 92%
“…The apextrin C-terminal domain (ApeC) takes its name from a sea urchin protein involved in larval 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 development. This domain has been recently recognized as a novel PRR in amphioxus, since two ApeC domain containing proteins were demonstrated to act as intra-and extra-cellular sensors of PGN and its component muramyl dipeptide (MDP) [78]. Apextrinlike proteins have been involved in pathogen recognition and inactivation also in echinoderms [79] and the over-expression of two apextrin-related transcripts in response to bacterial challenges has been reported in M. galloprovincialis [80].…”
Section: Extracellular Prrsmentioning
confidence: 99%
“…We thus decided to 413 interrogate specifically the populations of small RNAs mapping on Branchiostoma 414 pathogen genomes. Several pathogenic bacteria (Staphylococcus aureus, Vibrio 415 alginolyticus and Vibrio anguillarum; [92,93]) have been described in various 416 Branchiostoma species. We asked whether RNAi could target those pathogens in vivo.…”
mentioning
confidence: 99%